Literature DB >> 7227711

Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma.

M Kaku, T Nishiyama, K Yagawa, M Abe.   

Abstract

A human pancreatic carcinoma cell line of islet cell origin (QGP-1) has been established and maintained for over two years. The parent tumor and the cultured cell line produce carcinoembryonic antigen (CEA), and there is no evidence of hormone secretion from the tumor cells. The epithelioid cells, which had migrated from rounded, irregular cell aggregates, grow as a confluent monolayer with piling up of cells in some areas, and have a population doubling time of 3.5 days. The modal chromosome number was 50. Exponentially growing cultures produce 76.3 ng of CEA/10(6) cells after 7 days. CEA production was confirmed by immuno-peroxidase staining.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7227711

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  38 in total

1.  Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors.

Authors:  Rony A François; Kyungah Maeng; Akbar Nawab; Frederic J Kaye; Steven N Hochwald; Maria Zajac-Kaye
Journal:  J Natl Cancer Inst       Date:  2015-05-12       Impact factor: 13.506

2.  Monoclonal antibody to a human pancreatic carcinoma cell line recognizes gastrointestinal neoplasms.

Authors:  H J Kahn; H Yeger; R Loftus; M H Goldrosen
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

3.  Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.

Authors:  Aaron T Scott; Michelle Weitz; Patrick J Breheny; Po Hien Ear; Benjamin Darbro; Bart J Brown; Terry A Braun; Guiying Li; Shaikamjad Umesalma; Courtney A Kaemmer; Chandra K Maharjan; Dawn E Quelle; Andrew M Bellizzi; Chandrikha Chandrasekharan; Joseph S Dillon; Thomas M O'Dorisio; James R Howe
Journal:  Clin Cancer Res       Date:  2020-01-14       Impact factor: 12.531

4.  Establishment and characterization of a carcinoembryonic antigen producing cell line derived from human pancreatic exocrine cancer.

Authors:  N Yamaguchi; G Uozumi; H Ikeuchi; H Morioka; M Machino; K Kawai
Journal:  Gastroenterol Jpn       Date:  1983-12

5.  p53 tumour suppressor gene expression in pancreatic neuroendocrine tumour cells.

Authors:  C Bartz; C Ziske; B Wiedenmann; K Moelling
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

6.  A new human pancreatic carcinoma cell line developed for adoptive immunotherapy studies with lymphokine-activated killer cells in nude mice.

Authors:  B J Drucker; F M Marincola; D Y Siao; T A Donlon; C D Bangs; W D Holder
Journal:  In Vitro Cell Dev Biol       Date:  1988-12

7.  Sunitinib-Loaded Chondroitin Sulfate Hydrogels as a Novel Drug-Delivery Mechanism for the Treatment of Pancreatic Neuroendocrine Tumors.

Authors:  Xavier M Keutgen; Kimberly J Ornell; Alyx Vogle; Olga Lakiza; Jelani Williams; Paul Miller; Katelyn S Mistretta; Namrata Setia; Ralph R Weichselbaum; Jeannine M Coburn
Journal:  Ann Surg Oncol       Date:  2021-06-05       Impact factor: 5.344

8.  Molecular markers for novel therapeutic strategies in pancreatic endocrine tumors.

Authors:  Judith A Gilbert; Laura J Adhikari; Ricardo V Lloyd; Thorvardur R Halfdanarson; Michael H Muders; Matthew M Ames
Journal:  Pancreas       Date:  2013-04       Impact factor: 3.327

9.  Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues.

Authors:  S Jonas; M John; J Boese-Landgraf; R Häring; G Prevost; F Thomas; S Rosewicz; E O Riecken; B Wiedenmann; P Neuhaus
Journal:  Langenbecks Arch Chir       Date:  1995

Review 10.  Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types.

Authors:  Sucharitha Iyer; Sunita K Agarwal
Journal:  J Mol Endocrinol       Date:  2018-04-03       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.